News

The bases remain similar to those in DNA, allowing PNAs to target transcripts. As antisense molecules, PNAs bind to complementary messenger RNA (mRNA), blocking its function and inhibiting the ...
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...
Oligonucleotides work as short strands of synthetic DNA or RNA that can reduce ... $40 million from a series A and a group of execs from antisense oligonucleotide-focused Ionis.
Researchers have identified a never-before-seen mechanism that enables HIV-1 to evade the body's natural defenses and use it ...
In a groundbreaking discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have ...
In an important discovery, researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine have ...
Learn about April 2025’s top biotech deals, featuring major collaborations in bispecific antibodies, protein therapies, and ...
The scientists at the University of California, San Francisco, and Johns Hopkins University in Baltimore injected an ...
A new specialist manufacturing facility in Scotland could soon provide solutions to scaling challenges for vital ...
Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a ...
Known as antisense oligonucleotides, or ASOs for short, the new technique involves injecting a small piece of DNA into the cerebral spinal fluid of a child's spinal cord. The DNA then targets and ...